András Papp

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

Yuichiro Ogura, Johann Roider, Jean‐François Korobelnik et al. · American Journal of Ophthalmology · 2014 · 158 citations

Ocular Disease, Vitreous Body, Ophthalmology +6

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 105 citations · Full text

Faricimab Treat-and-extend, Diabetic Retinopathy, Ocular Disease +3

The SECURE Study

Rufino Silva, Ruth Axer‐Siegel, Bora Eldem et al. · Ophthalmology · 2012 · 90 citations

Engineering, Security Management, Usable Security +8

A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration

Glenn J. Jaffe, Dean Eliott, John A. Wells et al. · Ophthalmology · 2015 · 90 citations · Full text

Ocular Disease, Ophthalmology, Age-related Diseases +6